Neurogene Inc
NGNE
$38.41-5.95%
End of day · as of Aug 26, 2026, 8:02 PM ET
Mkt cap
$286.53M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-5.04
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Latest reported NGNE revenue for 2025-12-31 was $0. Net income was -$90.4M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. NGNE currently screens at market cap $286.5M.
Use this NGNE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NGNE income, balance, and cash tables.
Neurogene Inc (NGNE) is a biotechnology company in the Healthcare sector.
Latest cached Neurogene Inc (NGNE) net income for Dec 31, 2025 was -$90.4M. Statements: https://lician.com/financials/ngne
Neurogene Inc (NGNE) market capitalization is $286.5M on the latest cached snapshot.
Neurogene Inc (NGNE) cached previous close $40.84; day range $38.27 – $41.77; volume 180,073. Session quote: https://lician.com/quote/ngne
Neurogene Inc (NGNE) latest cached earnings event is "NGNE earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NGNE filing is 8-K · Aug 11, 2026. Filings: https://lician.com/sec/ngne